Industry news
Allergan and NuMedii form research alliance to identify new psoriasis treatments
NuMedii announced the formation of a research alliance with Allergan to explore new therapeutic options for the potential treatment of psoriasis. The companies will use NuMedii's predictive Big Data intelligence platform technology, which enables the discovery of new uses for medicines across a number of therapeutic areas. NuMedii has already generated multiple lead compounds/candidates by utilising its data intelligence technology for psoriasis, which will be the focus of the research alliance with Allergan.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
